HTA is supporting transformation in Health domain

We help deliver new Digital Health services, develop better tools to support the transformation in the Life Sciences sector.

Digital health
© Fraunhofer EMFT
Drug delivery systems development.
Bioreagent process development.

The HTA Health platform offers a single access point to the leading European research and technology infrastructures and to their rich network in the domain of medtech and life sciences.

Enabling new Digital Health services

New solutions to increase the standard of care and reduce costs are needed in the healthcare. In the undergoing transition a large proportion of services will be offered digitally in the future. HTA members offers our customers optimized solutions for a wide range of health and well-being services such as for patients & treatments monitoring as well for chronic diseases for the future digital health domain.

Areas of focus:

  • Drug delivery
  • Monitoring of patients, treatments & chronic diseases
  • Digital health from data acquisition to data analytics

Useful links

New tools to support the transformation in the Life Sciences sector

Aging populations, chronic and lifestyle diseases, disease outbreaks and technology advances such as recombinant technology and genome sequencing: all these factors are transforming the life sciences sector. HTA partners use their miniaturization, integration, and microengineering expertise to develop new devices, with a focus on components, tools, and systems for tissue engineering, toxicology and pharmacology, and on diagnostics and assays. Focus areas to be mentioned are organ-on-chip, diagnostics and recombinant bioreagents.

Areas of focus:

  • Organ-on-chip
  • Diagnostics
  • Recombinant bioreagents

Useful links


Related EU projects in HEALTH

Health Projects